BioXcel Therapeutics settlements

BioXcel Therapeutics is the subject of a $9,750,000 class action settlement covering investors who purchased or acquired BioXcel Therapeutics common stock between March 9, 2023, and June 28, 2023. The lawsuit alleged securities law violations during that period, and eligible shareholders may receive approximately $1.52 per share before deductions. A verified claim deadline of June 30, 2026 applies, and proof of purchase is required to file through the official claim form.

$1.52 potential payment
Free file on the official form

Check what you may be owed Free · takes 20 seconds

Published directory

1 published record

Proof required

False Advertising

BioXcel Therapeutics $9.75M Class Action Settlement

BioXcel Therapeutics agreed to a $9,750,000 settlement resolving a securities class action alleging the company misled investors between March and June 2023. Eligible investors who purchased BioXcel common stock during that window could recover roughly $1.52 per share before deductions. The claim filing window closed June 30, 2026.

Claim window closed Evidence-verified

Related companies with published settlements

Share this collection — free to repost with a link back.

There may be money with your name on it.

Free to browse and track. Every record shows its official-evidence status — and you open the official claim form yourself.

Check what you may be owed Browse all settlements